395 related articles for article (PubMed ID: 9171827)
1. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation.
Ye BH; Cattoretti G; Shen Q; Zhang J; Hawe N; de Waard R; Leung C; Nouri-Shirazi M; Orazi A; Chaganti RS; Rothman P; Stall AM; Pandolfi PP; Dalla-Favera R
Nat Genet; 1997 Jun; 16(2):161-70. PubMed ID: 9171827
[TBL] [Abstract][Full Text] [Related]
2. The proto-oncogene BCL-6 in normal and malignant B cell development.
Niu H
Hematol Oncol; 2002 Dec; 20(4):155-66. PubMed ID: 12469325
[TBL] [Abstract][Full Text] [Related]
3. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
4. BCL-6 regulates chemokine gene transcription in macrophages.
Toney LM; Cattoretti G; Graf JA; Merghoub T; Pandolfi PP; Dalla-Favera R; Ye BH; Dent AL
Nat Immunol; 2000 Sep; 1(3):214-20. PubMed ID: 10973278
[TBL] [Abstract][Full Text] [Related]
5. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
[TBL] [Abstract][Full Text] [Related]
6. Induction of BCL-6 gene expression by interferon-gamma and identification of an IRE in exon I.
Zhou G; Ono SJ
Exp Mol Pathol; 2005 Feb; 78(1):25-35. PubMed ID: 15596057
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional repressor BCL-6 immortalizes germinal center-like B cells in the absence of p53 function.
Kusam S; Vasanwala FH; Dent AL
Oncogene; 2004 Jan; 23(3):839-44. PubMed ID: 14737119
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of the LAZ3 (BCL6) proto-oncogene accompanies murine skeletal myogenesis.
Albagli-Curiel O; Dhordain P; Lantoine D; Auradé F; Quief S; Kerckaert JP; Montarras D; Pinset C
Differentiation; 1998 Nov; 64(1):33-44. PubMed ID: 9921651
[TBL] [Abstract][Full Text] [Related]
9. Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B.
Su GH; Chen HM; Muthusamy N; Garrett-Sinha LA; Baunoch D; Tenen DG; Simon MC
EMBO J; 1997 Dec; 16(23):7118-29. PubMed ID: 9384589
[TBL] [Abstract][Full Text] [Related]
10. Role for Bcl-6 in the generation and maintenance of memory CD8+ T cells.
Ichii H; Sakamoto A; Hatano M; Okada S; Toyama H; Taki S; Arima M; Kuroda Y; Tokuhisa T
Nat Immunol; 2002 Jun; 3(6):558-63. PubMed ID: 12021781
[TBL] [Abstract][Full Text] [Related]
11. Acetylation inactivates the transcriptional repressor BCL6.
Bereshchenko OR; Gu W; Dalla-Favera R
Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
[TBL] [Abstract][Full Text] [Related]
12. TH2 inflammation repressed by chemokines.
Canfield S; Rothman P
Nat Immunol; 2000 Sep; 1(3):189-90. PubMed ID: 10973271
[No Abstract] [Full Text] [Related]
13. Soluble antigen can cause enhanced apoptosis of germinal-centre B cells.
Pulendran B; Kannourakis G; Nouri S; Smith KG; Nossal GJ
Nature; 1995 May; 375(6529):331-4. PubMed ID: 7753199
[TBL] [Abstract][Full Text] [Related]
14. BCL-6: rearrangement and mutation in lymphoma.
Wagner SD; Kaeda JS
Methods Mol Med; 2005; 115():251-70. PubMed ID: 15998973
[TBL] [Abstract][Full Text] [Related]
15. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells.
Phan RT; Saito M; Basso K; Niu H; Dalla-Favera R
Nat Immunol; 2005 Oct; 6(10):1054-60. PubMed ID: 16142238
[TBL] [Abstract][Full Text] [Related]
16. Target genes downregulated by the BCL-6/LAZ3 oncoprotein in mouse Ba/F3 cells.
Hosokawa Y; Maeda Y; Seto M
Biochem Biophys Res Commun; 2001 May; 283(3):563-8. PubMed ID: 11341761
[TBL] [Abstract][Full Text] [Related]
17. [Bcl-6: a protooncogene co-involved in B-lymphocyte differentiation and in the pathogenesis of diffuse, large-cell non-Hodgkin's lymphomas of the B phenotype].
Pescarmona E
Pathologica; 1998 Feb; 90(1):81-2. PubMed ID: 9628984
[No Abstract] [Full Text] [Related]
18. Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6.
Kurata M; Maesako Y; Ueda C; Nishikori M; Akasaka T; Uchiyama T; Ohno H
Cancer Res; 2002 Nov; 62(21):6224-30. PubMed ID: 12414651
[TBL] [Abstract][Full Text] [Related]
19. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
[TBL] [Abstract][Full Text] [Related]
20. Expression of cholesteryl ester transfer protein (CETP) in germinal centre B cells and their neoplastic counterparts.
Ito K; Ishikawa F; Kanno T; Ishikawa Y; Akasaka Y; Akishima Y; Ishii T; Terayama Y; Sugimoto M; Watanabe T; Mori S
Histopathology; 2004 Jul; 45(1):73-81. PubMed ID: 15228446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
